Kameel D. Farag

CIK: 0002093620

Transaction Breakdown

Open Market Buys (P)2 (13.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)13 (86.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

AKTX

Akari Therapeutics Plc

Officer

BIVI

BIOVIE INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (15 total)

AKTX
Akari Therapeutics Plc
Aug 17, 2026
Award(A)
Direct
1.7K shares at avg. $7.52$13K
AKTX
Akari Therapeutics Plc
Jul 16, 2026
Award(A)
Direct
1.1K shares at avg. $11.50$13K
AKTX
Akari Therapeutics Plc
Jun 24, 2026
Award(A)
Direct
1.4K shares at avg. $9.32$13K
AKTX
Akari Therapeutics Plc
Jun 24, 2026
Award(A)
Direct
1.6K shares at avg. $8.28$13K
AKTX
Akari Therapeutics Plc
Jun 24, 2026
Award(A)
Direct
2.5K shares at avg. $5.12$13K
AKTX
Akari Therapeutics Plc
Jun 24, 2026
Award(A)
Direct
3.7K shares at avg. $3.49$13K
AKTX
Akari Therapeutics Plc
Jun 24, 2026
Award(A)
Direct
1K shares at avg. $13.00$13K
AKTX
Akari Therapeutics Plc
Jun 24, 2026
Award(A)
Direct
7.4K shares at avg. $3.74$28K
AKTX
Akari Therapeutics Plc
Jun 24, 2026
Award(A)
Direct
1.2K shares at avg. $10.02$13K
BIVI
BIOVIE INC.
Jan 5, 2026
Award(A)
Stock Option (right to buy)
Direct
57.5K shares-
AKTX
Akari Therapeutics Plc
Dec 16, 2025
Purchase(P)
Warrants to purchase American Depositary Shares ("ADRs")
Direct
24.7K shares-
AKTX
Akari Therapeutics Plc
Dec 16, 2025
Purchase(P)
Pre-Funded Warrants to purchase ADRs
Direct
24.7K shares at avg. $0.40-
AKTX
Akari Therapeutics Plc
Nov 1, 2025
Award(A)
Direct
26.6K shares at avg. $0.75$20K
AKTX
Akari Therapeutics Plc
Nov 1, 2025
Award(A)
Direct
32K shares at avg. $0.75$24K
AKTX
Akari Therapeutics Plc
Oct 22, 2025
Award(A)
Direct
6.3K shares at avg. $0.74$5K

		Type	Shares	Price		Ownership
Aug 17, 2026	AKTX Akari Therapeutics Plc	Award(A)	1,728	$7.52	$12,995	Direct
Jul 16, 2026	AKTX Akari Therapeutics Plc	Award(A)	1,130	$11.50	$12,995	Direct
Jun 24, 2026	AKTX Akari Therapeutics Plc	Award(A)	1,395	$9.32	$13,001	Direct
Jun 24, 2026	AKTX Akari Therapeutics Plc	Award(A)	1,570	$8.28	$13,000	Direct
Jun 24, 2026	AKTX Akari Therapeutics Plc	Award(A)	2,539	$5.12	$13,000	Direct
Jun 24, 2026	AKTX Akari Therapeutics Plc	Award(A)	3,725	$3.49	$13,000	Direct
Jun 24, 2026	AKTX Akari Therapeutics Plc	Award(A)	1,000	$13.00	$13,000	Direct
Jun 24, 2026	AKTX Akari Therapeutics Plc	Award(A)	7,353	$3.74	$27,500	Direct
Jun 24, 2026	AKTX Akari Therapeutics Plc	Award(A)	1,248	$10.02	$12,505	Direct
Jan 5, 2026	BIVI BIOVIE INC.	Award(A) Stock Option (right to buy)	57,500	-	-	Direct
Dec 16, 2025	AKTX Akari Therapeutics Plc	Purchase(P) Warrants to purchase American Depositary Shares ("ADRs")	24,745	-	-	Direct
Dec 16, 2025	AKTX Akari Therapeutics Plc	Purchase(P) Pre-Funded Warrants to purchase ADRs	24,745	$0.40	-	Direct
Nov 1, 2025	AKTX Akari Therapeutics Plc	Award(A)	26,619	$0.75	$19,964	Direct
Nov 1, 2025	AKTX Akari Therapeutics Plc	Award(A)	32,000	$0.75	$24,000	Direct
Oct 22, 2025	AKTX Akari Therapeutics Plc	Award(A)	6,277	$0.74	$4,645	Direct

1-15 of 15 transactions

About Farag Kameel D.

Farag Kameel D. (SEC CIK 0002093620) files insider reports with the SEC as Interim CFO of Akari Therapeutics Plc (AKTX) and Director of BIOVIE INC. (BIVI).

Signal8 holds 9 ownership filings by Farag Kameel D. (2 Form 3, 7 Form 4), filed between Oct 24, 2025 and Aug 19, 2026. Those filings report 15 transactions, from Oct 22, 2025 to Aug 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Farag Kameel D.'s filings is in TAMPA, FL.

Recent filings by Farag Kameel D.

Aug 17, 2026: Grant or award of AKTX shares (Form 4, code A).
Jul 16, 2026: Grant or award of AKTX shares (Form 4, code A).
Jun 24, 2026: Grants or awards of AKTX shares (7 lines, Form 4, code A).
Jan 5, 2026: Grant or award of BIVI derivative securities (Form 4, code A).
Dec 16, 2025: Open-market purchases of AKTX derivative securities (2 lines, Form 4, code P).

Other insiders filing for Akari Therapeutics Plc (AKTX)

How to read Form 4 transaction codes